Adhd - Articles - Page 8 | CARLAT PUBLISHING

ADHD Overdiagnosis

January 1, 2017

Alyson Harrison, PhD Clinical director, Regional Assessment and Resource Center, Queen’s University, Kingston, Ontario Dr. Harrison has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this interview, Dr. Harrison shares her insight on adult ADHD. She runs a clinic for adult ADHD screening at Queens University near Ottawa. Most of the people she sees are university students who think they have ADHD but were never diagnosed. The clinic now has data on 260 students.

Can a 10-Minute Intervention Improve Sleep in Children With ADHD?

January 1, 2017

Colleen Ryan, MD

Colleen Ryan, MD Dr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We know that kids with ADHD often have sleep issues, and that the stimulants we use to treat them can cause insomnia. What would happen if we focused our treatment on the insomnia portion of ADHD? Presumably kids would sleep better, but would their ADHD symptoms also improve?

Meds for ADHD Not Working? Add CBT

May 1, 2016

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medication is an effective and necessary treatment for many adolescents struggling with ADHD. Unfortunately, even when patients and parents report significant relief from meds, symptoms persist, which can lead to ongoing problems at school, at home, and with peers. That’s why psychosocial interventions are an important part of any treatment plan for adolescents with ADHD.

The Explosion of the ADHD Diagnosis: The Key Causes

January 1, 2016

Stephen P. Hinshaw, PhD

Rates of ADHD have increased significantly in the U.S. over the past several years, leading to an ongoing debate about the validity of the disorder. Because you are likely to be asked by patients (or their parents) about this issue, it’s helpful for you to have some background in exactly how much the prevalence has increased, and what factors may be driving this trend.

Newer Stimulant Preparations: Are They Worth the Cost?

January 1, 2016

We are generally skeptical of the utility of newly approved stimulant preparations, unless they are actually new molecules. Over the last few years, several of these variations on older themes have been introduced; here is a handy table for your perusal should you be curious.

ADHD and Executive Functioning Disorder

January 1, 2016

Dr. Brown is a pioneer of the executive function impairment concept. In this interview, he explains this impairment and how it relates to the current understanding of ADHD in children and adolescents.

Vyvanse: A Look at America’s Most Prescribed Stimulant

November 1, 2014

Talia Puzantian, PharmD, BCPP

Why has Vyvanse become by far the most prescribed stimulant in the United States? Great marketing? A great product? Some combination of the two?

Intuniv: Exorbitant, Sedating, and Second-Line

November 1, 2014

Talia Puzantian, PharmD, BCPP

Guanfacine, a drug originally used to treat hypertension, has been reformulated and now has new life as a medication to treat ADHD in children.

A Balanced Approach to Treating ADHD

November 1, 2014

Lawrence H. Diller, MD

Lawrence Diller, MD. Behavioral/Developmental Pediatrician in Private Practice. Assistant Clinical Professor University of California, San Francisco.
Dr. Diller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Read about this balanced approach, including alternatives to medications, in treating children and adolescents with ADHD in an interview with pediatrician and author Lawrence Diller, MD.